Neratinib in the early-stage/extended adjuvant breast cancer patient: Q&A.

O'Shaughnessy, Joyce A; O'Regan, Ruth; Isaacs, Claudine

O'Shaughnessy, Joyce A; O'Regan, Ruth; Isaacs, Claudine.

Afiliación

O'Shaughnessy JA; Baylor University Medical Center, Dallas, Texas.
O'Regan R; Breast Cancer Research Program, Texas Oncology, US Oncology, Dallas, Texas.
Isaacs C; Hematology/Oncology Faculty, University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin.

Clin Adv Hematol Oncol ; 18 Suppl 12(8): 16-17, 2020 Aug.

Article en En | MEDLINE | ID: mdl-33843847

Asunto(s)

Neoplasias de la Mama; Quinolinas; Neoplasias de la Mama/tratamiento farmacológico; Quimioterapia Adyuvante; Femenino; Humanos; Quinolinas/uso terapéutico; Receptor ErbB-2

Buscar en Google

Imprimir

XML

PubMed Links

Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinolinas / Neoplasias de la Mama Límite: Female / Humans Idioma: En Revista: Clin Adv Hematol Oncol Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article

Buscar en Google

Imprimir

XML

PubMed Links